Tue 18'th Sep 2018
VistaGen Therapeutics Inc Stock Analysis
Technical stock analysis for Tue 18'th Sep 2018
|Shorts||13.59% ( 2018-08-31 )|
VistaGen Therapeutics Inc gained 1.53% in the last trading day, rising from $1.31 to $1.33 The price has been going up and down for this period, and there has been a -5% loss for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 47 350 more shares were traded than the day before. In total, 161 080 shares bought and sold for approximately $214 236.00.
Given the current horizontal trend you can expect VistaGen Therapeutics Inc with 90% probability to be traded between $1.21 and $1.47 at the end of this period with 90% probability. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the roof. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
There are mixed signals in the stock today. VistaGen Therapeutics Inc holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $1.35 and $1.33. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Monday September 17, 2018, which indicates further gains until a new top pivot has been found. VistaGen Therapeutics Inc has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Relative Strength Index (RSI)
RSI14 is 39 and the stock is currently not being overbought or oversold
Support & Resistance
VistaGen Therapeutics Inc finds support from accumulated volume at $1.31.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.08 between high and low, or 6.08%. For the last week, the stock has had a daily average volatility of 6.58%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
VistaGen Therapeutics Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.Click for Top 5 Sell Candidates
|VTGN $1.33 $0.02(1.53%)|
VTGN is up $0.02 today, but where's it headed in October?
|Zacks Investment Research is releasing its prediction for VTGN based on the 1-3 month system that more than doubles the S&P 500.
Click here – the VTGN analysis is free »